PacificHealth Laboratories, Inc.
Other OTCTotal Valuation
PacificHealth Laboratories, Inc. carries a market capitalization of 438,307.00, placing it among publicly traded companies globally. Its enterprise value stands at 2.24M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 438,307.00 |
| Enterprise Value | 2.24M |
Share Statistics
PacificHealth Laboratories, Inc. currently has 20.87M shares outstanding.
| Shares Outstanding | 20.87M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.38, and the price-to-book ratio stands at -0.12.
| PE Ratio | N/A |
| PS Ratio | 0.38 |
| PB Ratio | -0.12 |
| P/TBV Ratio | 3.03 |
| P/FCF Ratio | -6.10 |
| P/OCF Ratio | -4.25 |
Enterprise Valuation
| EV / Sales | 0.34 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
PacificHealth Laboratories, Inc. maintains a current ratio of 1.58, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.63, indicating elevated leverage, while an interest coverage ratio of -49.97 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.58 |
| Quick Ratio | 0.86 |
| Debt / Equity | 6.63 |
| Debt / EBITDA | -0.06 |
| Interest Coverage | -49.97 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -40.07 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.63 |
Income Statement
Over the trailing twelve months, PacificHealth Laboratories, Inc. generated 6.67M in revenue and converted that into -943,600.00 in net income, yielding earnings per share of -0.05. EBITDA reached -861,233.00, while operating income came in at -926,835.00.
| Revenue | 6.67M |
| Gross Profit | 2.57M |
| Operating Income | -926,835.00 |
| Pretax Income | -943,600.00 |
| Net Income | -943,600.00 |
| EBITDA | -861,233.00 |
| EBIT | -926,835.00 |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
PacificHealth Laboratories, Inc. holds 324,477.00 in cash and equivalents against 54,864.00 in total debt, resulting in a net debt position of -219,613.00. Total book value stands at -20.54M, with working capital of 676,050.00 providing operational flexibility.
| Cash & Cash Equivalents | 324,477.00 |
| Total Debt | 54,864.00 |
| Net Debt | -219,613.00 |
| Equity (Book Value) | -20.54M |
| Book Value Per Share | -0.98 |
| Working Capital | 676,050.00 |
Cash Flow
PacificHealth Laboratories, Inc. produced -589,528.00 in operating cash flow over the past twelve months. After subtracting -178,845.00 in capital expenditures, free cash flow totaled -768,373.00 - equivalent to -0.04 per share.
| Operating Cash Flow | -589,528.00 |
| Capital Expenditures | -178,845.00 |
| Free Cash Flow | -768,373.00 |
| FCF Per Share | -0.04 |
Margins
PacificHealth Laboratories, Inc. operates with a gross margin of 38.50, reflecting its pricing power and cost economics. The operating margin of -13.90 and net profit margin of -14.15 provide insight into operational efficiency.
| Gross Margin | 38.50 |
| Operating Margin | -13.90 |
| Pretax Margin | -14.15 |
| Profit Margin | -14.15 |
| EBITDA Margin | -12.92 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.88 |
| FCF Yield | -16.40 |
Scores
PacificHealth Laboratories, Inc. posts an Altman Z-Score of -10.96, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -10.96 |